Completed NA INTERVENTIONAL 2-arm NCT01443780

Intervention With Selenium and Q10 on Cardiovascular Mortality and Cardiac Function in the Elderly Population in Sweden (KiSel-10)

Kisel-10- a Prospective Randomized Double-blind Placebo Controlled Study of the Results of Intervention With Selenium and Coenzyme Q10 Combined, Regarding Effect With Emphasis on Cardiovascular Mortality and Morbidity.

Sponsor: Ostergotland County Council, Sweden

Conditions Cardiac Function Cardiovascular Mortality

Interventions Selenium and ubiquinon (Q10) combined

Updated 6 times since 2017 Last updated: Sep 30, 2011 Started: Jan 31, 2003 Primary completion: Feb 28, 2010 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiac Function and Cardiovascular Mortality and is currently completed. Ostergotland County Council, Sweden leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ostergotland County Council, Sweden
Pharma Nord
The Swedish Research Council
University Hospital, Linkoeping

Data source: University Hospital, Linkoeping

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Linköping, Sweden